Core Viewpoint - The company, Baolande (688058.SH), anticipates a net loss of approximately 75 million yuan for the year 2025, compared to the previous year, primarily due to reduced or delayed procurement demand from some downstream customers and a strategic contraction of certain business lines [1] Group 1 - The expected net loss for 2025 is around 75 million yuan, indicating a significant decline compared to the previous year's profit [1] - The decline in revenue is attributed to decreased procurement demand from customers and adjustments in business lines based on market demand and product competitiveness [1] - Despite the anticipated loss, the company continues to maintain high levels of R&D investment, which is expected to increase compared to the previous year [1] Group 2 - The company is implementing cost reduction and efficiency enhancement measures while still increasing R&D investment [1] - The company expects to achieve profitability in the fourth quarter of 2025 as a result of optimizing its business structure and strengthening its core customer base [1]

Core Viewpoint - Baoland (688058.SH) expects to report a net loss attributable to shareholders of approximately 75 million yuan for the year 2025, compared to the previous year [1] Group 1: Financial Performance - The anticipated net loss is primarily due to a decrease or delay in procurement demand from some downstream customers [1] - The company's revenue is expected to decline as it has consolidated certain business lines in response to market demand and product competitiveness [1] - Despite the expected loss, the company plans to maintain high levels of R&D investment, which is projected to increase compared to the previous year [1] Group 2: Future Outlook - The company aims to achieve a turnaround in the fourth quarter, expecting to return to profitability in that single quarter [1] - The optimization of the company's business structure and the strengthening of its core customer base are expected to contribute to this recovery [1]

Group 1 - Xianghe Industrial signed a contract worth 43.1041 million yuan with China Railway 15th Bureau, accounting for approximately 6.5% of the company's projected revenue for 2024 [1] - Dayu Water-saving's subsidiary won a bid for a project valued at 133 million yuan, with a construction period of 545 days [2] - China National Materials International's subsidiary signed a contract worth 299 million Canadian dollars for engineering design and procurement services [3] Group 2 - Baoland expects a net loss of approximately 75 million yuan for 2025, compared to a loss of 58.7224 million yuan in the previous year [4] - Changhong High-tech received an administrative regulatory decision due to inadequate internal controls and improper revenue recognition [5] - Debon Stock will be suspended from trading on January 21, 2026, pending a decision on its delisting [6] Group 3 - Haitai Technology anticipates a net profit increase of 226.86% to 323.97% for 2025, with an expected profit of 51.5 million to 66.8 million yuan [7] - Fushun Special Steel expects a net loss of 770 million to 870 million yuan for 2025, compared to a profit of 112 million yuan in the previous year [8] - Rejing Bio forecasts a net loss of 210 million to 230 million yuan for 2025, compared to a loss of 191 million yuan in the previous year [10] Group 4 - Sanyou Chemical expects a net profit of approximately 91 million yuan for 2025, a decrease of about 82% compared to the previous year [11] - Lianhuan Pharmaceutical received approval for clinical trials of a new drug for benign prostatic hyperplasia [12] - Samsung New Materials anticipates a net loss for 2025, indicating a decline in operational performance [13] Group 5 - Jinggong Technology expects a net profit increase of 36.1% to 70.13% for 2025, with an estimated profit of 200 million to 250 million yuan [14] - Zhongsheng Pharmaceutical's subsidiary signed a licensing agreement for the production and commercialization of RAY1225 injection, with total payments expected to reach 1 billion yuan [15] - Hengshuai shares saw a reduction of 600,000 convertible bonds held by its controlling shareholder [16] Group 6 - Buchang Pharmaceutical plans to repurchase shares worth 60 million to 120 million yuan for employee stock ownership plans [17] - Baike Bio expects a net loss of 220 million to 280 million yuan for 2025, marking a shift from profit to loss [18] - Weishi Electronics anticipates a net profit decrease of 53.27% to 61.61% for 2025, with expected profits of 21.49 million to 26.16 million yuan [19] Group 7 - China Automotive Research expects a net profit increase of 17.85% for 2025, with a projected profit of 1.06 billion yuan [20] - Hualan Biological's controlling shareholder raised the upper limit of its shareholding plan to 86.66 yuan per share [22] - Nasda anticipates a net loss for 2025, indicating a decline in financial performance [23] Group 8 - Haizheng Pharmaceutical received a warning letter from the Zhejiang Securities Regulatory Commission for financial data inaccuracies [24] - Mengguli received an administrative regulatory decision for accounting errors in its financial reports [25] - Zhongguancun's subsidiary received acceptance for a drug application for a heart-related treatment [26] Group 9 - Hosheng Silicon Industry was ordered to correct information disclosure violations by the Zhejiang Securities Regulatory Commission [27] - Meiteng Technology expects a net profit decrease of 22.4551 million to 28.5285 million yuan for 2025, a reduction of 55.21% to 70.14% [28] - Sanwei Co. received a warning letter for financial irregularities related to related party transactions [29] Group 10 - Ganyue Expressway expects a net profit increase of 3.18% for 2025, with a projected profit of 1.32 billion yuan [30] - Xinhang New Materials plans to acquire 51% of Hairete for 12.8826 million yuan [31] - China Software anticipates a net loss of 41 million to 49 million yuan for 2025, an improvement from the previous year's loss [32] Group 11 - Rongsheng Development expects a net loss for 2025, with losses not exceeding the previous year's audited net assets [33] - Northern Rare Earth anticipates a net profit increase of 117% to 135% for 2025, with expected profits of 2.176 billion to 2.356 billion yuan [34] - Energy-saving Wind Power received renewable energy subsidies totaling 1.507 billion yuan, a 122.74% increase from the previous year [35] Group 12 - Dongzhu Ecology expects a net loss of 935 million to 1.135 billion yuan for 2025, compared to a loss of 630 million yuan in the previous year [36] - Jingneng Real Estate anticipates a net loss of 986 million to 1.315 billion yuan for 2025, compared to a loss of 109 million yuan in the previous year [37] - Hailu Heavy Industry signed new orders worth 1.941 billion yuan for 2025, with total orders on hand amounting to 3.597 billion yuan [38] Group 13 - Dalian Thermal Power expects a net loss of 92 million to 112 million yuan for 2025, compared to a loss of 146 million yuan in the previous year [39] - Jiangsu Sop expects a net profit decrease of 52.99% to 62.4% for 2025, with profits projected between 8 million to 10 million yuan [40] - Lian Technology plans to initiate preparations for issuing H-shares and listing on the Hong Kong Stock Exchange [42] Group 14 - Zhenyang Development expects a net profit decrease of 58.13% to 64.94% for 2025, with profits projected between 67 million to 80 million yuan [43] - Sheneng Co. reported a 1.7% decrease in power generation for 2025, with total generation of 57.654 billion kWh [44] - XGIMI Technology's subsidiary received a development notification from a well-known domestic automotive manufacturer [45] Group 15 - Wanhua Chemical's MDI Phase II facility resumed production after maintenance [46] - Daqing Energy expects a net loss of 1 billion to 1.3 billion yuan for 2025, with a reduction in losses compared to the previous year [47]

Core Viewpoint - Baolande (688058) is expected to report a net loss of approximately 75 million yuan for the fiscal year 2025, compared to a loss of 58.72 million yuan in the same period last year [1] Group 1: Financial Performance - The projected net loss for 2025 is significantly higher than the previous year's loss, indicating a worsening financial situation for the company [1] - The decline in financial performance is attributed to reduced or delayed procurement demand from some downstream customers [1] Group 2: Business Operations - The company has decided to scale back certain business lines in response to market demand and product competitiveness, contributing to a decrease in operating revenue [1]

Core Viewpoint - Baolande (688058.SH) is expected to report a net loss attributable to shareholders of approximately 75 million yuan for the fiscal year 2025, indicating a significant decline compared to the previous year [1] Financial Performance - The projected net profit attributable to shareholders, excluding non-recurring gains and losses, is estimated to be around -102 million yuan for 2025 [1] - The anticipated loss is primarily due to a decrease or delay in procurement demand from some downstream customers and a reduction in business lines in response to market demand and product competitiveness, leading to a decline in operating revenue [1] Research and Development - The company continues to maintain a high level of investment in research and development, with R&D expenditures expected to increase compared to the previous year, despite the implementation of cost reduction and efficiency enhancement measures in 2025 [1] Future Outlook - The company anticipates achieving profitability in the fourth quarter, driven by the optimization of its business structure and further strengthening of its core customer base [1]

证券代码：688058 证券简称：宝兰德 公告编号：2026-003 北京宝兰德软件股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 北京宝兰德软件股份有限公司（以下简称"公司"） 2025 年 8 月 27 日召开 了第四届董事会第九次会议，审议通过了《关于变更注册资本、修订<公司章 程>并办理工商登记的议案》，上述议案亦已由 2025 年 9 月 17 日召开的 2025 年 第二次临时股东会审议通过。具体内容详见公司于 2025 年 8 月 28 日在上海证 券交易所网站（www.sse.com.cn）披露的《北京宝兰德软件股份有限公司关于 变更公司注册资本、修订<公司章程>并办理工商变更登记的公告》（公告编号： 2025-041）。 近日，公司完成了上述事项的工商变更登记，并取得了北京市顺义区市场 监督管理局换发的《营业执照》，具体登记信息如下： 经批准的项目，经相关部门批准后依批准的内容开展经营活动；不得从事国家 和本市产业政策禁止和限制类项目的经营活动。） ...

Core Viewpoint - Baolande (688058.SH) is expected to report a net loss attributable to shareholders of approximately 75 million yuan for the fiscal year 2025, indicating a significant decline compared to the previous year [1] Financial Performance - The projected net profit attributable to shareholders, excluding non-recurring gains and losses, is estimated to be around -102 million yuan for 2025 [1] - The anticipated loss is primarily due to a decrease or delay in procurement demand from some downstream customers and a contraction in certain business lines in response to market demand and product competitiveness [1] Research and Development - The company continues to maintain a high level of investment in research and development, with an increase in R&D spending expected in 2025 despite the focus on cost reduction and efficiency improvement [1] Business Outlook - The company anticipates a turnaround in the fourth quarter, expecting to achieve profitability in that quarter as a result of optimizing its business structure and strengthening its core customer base [1]

宝兰德公告，预计2025年年度实现归属于母公司所有者的净利润亏损7500万元左右，上年同期净利润亏 损5872.24万元。预计2025年年度实现归属于母公司所有者扣除非经常性损益后的净利润亏损1.02亿元左 右，上年同期净利润亏损5478.94万元。2025年度归属于母公司所有者的净利润亏损主要系本年度内公 司部分下游客户采购需求有所减少或延缓以及公司结合市场需求、产品竞争力等因素收敛部分业务条线 导致公司营业收入有所下滑；同时，公司始终保持较高的研发投入，在2025年度推进实施降本增效的背 景下，研发投入比上年度仍有所增长等。 ...

证券代码：688058 证券简称：宝兰德 公告编号：2026-002 北京宝兰德软件股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 （1）经财务部门初步测算，预计 2025 年年度实现归属于母公司所有者的净 利润与上年同期相比将出现亏损，实现归属于母公司所有者的净利润-7,500 万元 左右。 （2）经财务部门初步测算，预计 2025 年年度实现归属于母公司所有者扣除 非经常性损益后的净利润-10,200 万元左右。 二、上年同期业绩情况和财务状况 （一）利润总额：-6,577.48 万元； 归属于母公司所有者的净利润：-5,872.24 万元； 归属于母公司所有者的扣除非经常性损益的净利润：-5,478.94 万元。 （二）每股收益：-0.79 元。 三、本期业绩变化的主要原因 2025 年度归属于母公司所有者的净利润亏损主要系本年度内公司部分下游 客户 ...

证券代码：688058 证券简称：宝兰德 公告编号：2026-001 北京宝兰德软件股份有限公司 关于2023年员工持股计划注销实施的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 注销原因：鉴于市场环境与公司制定员工持股计划时已经发生了重大变化， 继续实施2023年员工持股计划将难以达到预期激励目的和效果，公司董事会已决定 终止公司2023年员工持股计划。公司将已终止的2023年员工持股计划股票1,894,393 股进行注销。 本次注销股份的有关情况 （一）2025年8月27日，公司召开第四届董事会第九次会议，审议通过《关于注 销已终止的"2023年员工持股计划"股票的议案》。具体内容详见公司于2025年8月 28日在上海证券交易所网站（www.sse.com.cn）披露的《北京宝兰德软件股份有 限公司关于注销已终止的"2023年员工持股计划"股票的公告》（公告编号：2025-040） 。2025年9月17日，公司召开2025年第二次临时股东会，审议通过了前述议案。 （二）2025年9月18日，公司 ...